Utilisateur
Lytic (phage replicates, lyses cell) and lysogenic (phage integrates into host chromosome as a prophage).
Virulent phage only perform lytic growth; temperate phage can choose lytic OR lysogenic pathways.
It is linear dsDNA, has 12-bp complementary 5′ overhangs, and circularizes via host ligase sealing the cohesive ends.
Circularization makes the late gene cluster continuous, organizes genes by function, and positions proteins near the DNA sites they regulate
t=0 DNA injection → t=3 early mRNAs → t=5 delayed early mRNAs → t=6 DNA replication → t=9 late mRNAs → t=45 lysis.
(Structural proteins made ~t=10).
Make their own RNAP (T7) or modify host RNAP to recognize phage promoters (T4). λ instead uses anti-terminators.
PL → N (anti-terminator), PR → Cro (repressor of lysogenic genes).
N binds nut sites in mRNA, interacts with RNAP, and enables RNAP to read through intrinsic terminators (tL1, tR1).
Cro binds OR/OL to repress cI, and prevents lysogeny by blocking repressor synthesis.
DNA replication genes (O, P), recombination genes, and Q anti-terminator.
Q binds qut sites, modifies RNAP, and allows readthrough of tR4 → enabling late gene expression (head, tail, lysis genes).
Deletions removing tL1, and substitutions replacing DNA containing tR2, so N was no longer required.
Terminators control timing, and anti-terminators like N allow temporal ordering of early → delayed early gene expression.
Turbid plaque centers and superinfection immunity (lysogens cannot be infected by more λ).
Lysogens have high CI levels, CI immediately binds OR/OL, and this shuts off PR and PL → no lytic cycle
CI = “See I already live here—no new λ allowed.”
cI⁻: no repressor → only lytic.
cII⁻: cannot activate cI → fail lysogeny.
cIII⁻: cannot stabilize CII → fail lysogeny.
Mutations in OR or OL that prevent CI binding → thus always lytic and can superinfect lysogens.
Establishment via pRE activated by CII, and maintenance via pRM activated by CI itself.
Strong CII activity, high initial CI synthesis, and CI concentration exceeding available operator sites.
CIII protects CII from degradation and stabilizes it long enough to activate pRE.
At low CI, it activates pRM; at high CI, it represses pRM via binding OR3.
CI binds OR1 > OR2 > OR3 (outside-in).
Cro binds OR3 > OR2 > OR1 (inside-out).
CI binds closest to lytic promoters first to shut them down.
Cro binds closest to pRM first to block CI expression.
Full repression of PR & PL plus repression of pRM, preventing CI overaccumulation.
High CI → lysogeny; low CI → lytic growth.
Cro, CII, and CIII—Cro represses CI; CII activates CI; CIII stabilizes CII
CII stability, because CII initiates CI expression from pRE.
(Many slides highlight this as the deciding factor.)
It undergoes lytic growth, because no CII means no CI expression from pRE → CI never reaches level needed for lysogeny.
CII becomes unstable, decreasing CI production → lytic pathway favored.
Cro binds OR3 first, blocking pRM, preventing CI production → lytic cycle.
pRM becomes hyperactive, producing excess CI → lysogeny persists and induction becomes difficult.
CI cannot block PR → Cro accumulates, repressing CI synthesis and driving lytic growth.
It proceeds through lytic growth, because vir mutations prevent CI binding → lysogens become superinfectable.
N becomes unnecessary; early transcription reads through → disrupted timing and premature expression of replication genes.
Reduced Cro → less repression of pRM → CI rises → lysogeny more likely.
RNAP cannot anti-terminate at nut sites, so delayed early genes (O, P, Q) fail to be expressed → lytic cycle collapses.
Very strong CI accumulation → phage shows high lysogenization frequency and rarely enters lytic cycle.
CI rises unopposed → lysogeny almost always occurs.
OR3 cannot bind CI or Cro → pRM is always active → CI always expressed → constitutive lysogeny.
Incoming phage is immediately repressed at PR/PL → immunity → no lysis.
Loss of CI repression → PR/PL turn ON → induction of lytic cycle.
Q cannot bind → RNAP cannot anti-terminate → no head/tail gene expression → no virion assembly.
